HOME >> MEDICINE >> NEWS
Unlocking colon cancer with key of prevention

HOUSTON - An international team of scientists reports that a single 400-milligram daily dose of celecoxib, commonly called Celebrex and manufactured by Pfizer, significantly reduced recurrence of adenomas, or pre-malignant colon tumors - within three years of previous adenoma removal.

The New England Journal of Medicine today published findings from the Prevention of Spontaneous Adenomatous Polyps (PreSAP) study, involving more than 1,550 participants at 107 sites in 32 countries on six continents. The study was led by Nadir Arber, M.D., chair of the Integrated Cancer Prevention Center and professor of medicine and gastroenterology at the Tel Aviv Sourasky Medical Center and Bernard Levin, M.D., vice president of Cancer Prevention and Population Sciences at The University of Texas M. D. Anderson Cancer Center.

"Celecoxib 400 mg once daily significantly reduced colorectal adenoma occurrence, with a greater effect on advanced adenomas," said Arber.

As excess amounts of the protein cyclooxygenase (COX-2) are associated with adenomas and colon cancer, PreSAP researchers studied celecoxib - a selective COX-2 inhibitor - to prevent the pre-cancerous lesions.

"There is no doubt that celecoxib is an effective agent in reducing the size and occurrence of adenomas in patients with higher risks for colorectal cancer," said Levin.

In the placebo-controlled, double-blind PreSAP trial, study leaders randomly assigned participants to receive either a single 400-mg dose of celecoxib (approximately 930 subjects) or a placebo (nearly 630 subjects). Subjects received colonoscopies after one and three years to detect potential pre-malignant tumors and their sizes, as well the overall adenoma burdens for participants. All polyps were removed and examined by study pathologists.

At the conclusion of the trial, the cumulative adenoma rate for the celecoxib study group was 33.6 percent, while the cumulative rate of adenoma deve
'"/>

Contact: Claire Tyson
ctyson@mdanderson.org
713-794-1731
University of Texas M. D. Anderson Cancer Center
30-Aug-2006


Page: 1 2

Related medicine news :

1. Ireland Cancer Center researcher lays out benefits of aspirin to prevent colon cancer
2. New technique effective in closing accidental colonoscopy wounds
3. Uveal melanoma patients at higher risk for colon cancer
4. No data to support leaving small colon polyps in place
5. Tequila raw ingredient being developed into drug-carrier that targets colon diseases
6. Blueberries contain chemical that may help prevent colon cancer
7. Lymph node evaluation linked to improved survival for colon cancer patients
8. Mount Sinai and EXACT Sciences announce study results on study stool DNA testing for colon cancer
9. Report calls for using heated chemotherapy after colon cancer surgery to optimize patient survival
10. Virtual colonoscopy considerably more expensive
11. Scientists stop colon cancer growth in mice by blocking just one enzyme

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/3/2020)... KY (PRWEB) , ... September 03, 2020 , ... ... living with memory impairment, has announced the Best Memory Care Facilities in Louisville, ... experts, facility features and amenities. , According to the Alzheimer’s Association ...
(Date:9/2/2020)... , ... September 02, 2020 , ... ... software for healthcare payers administering Medicare Advantage and Special Needs plans, is proud ... by America’s Health Insurance Plans (AHIP). RAM is supporting the event as a ...
(Date:9/1/2020)... ... September 01, 2020 , ... KitoTech ... million convertible note financing, which will be used to accelerate the commercialization of ... this financing, the company will continue to expand its customer base of healthcare ...
(Date:9/1/2020)... ... ... As fall and winter swiftly approach and many businesses cut costs to ... time to expand and grow into a full-fledged natural health clinic over the past ... relaunching its brand new website, expanding its services menu and has recruited top-tier healthcare ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... are joining biomedical engineers from Carnegie Mellon University (CMU) to develop a new ... who have undergone open heart surgery. , The AGH/CMU team was recently awarded ...
Breaking Medicine News(10 mins):
(Date:8/27/2020)... ... 27, 2020 , ... Trella Health, the leading source of ... cloud CRM, marketing automation, and contact center solutions for senior living communities and ... Trella’s performance intelligence data and insights into Enquire’s CRM solution to serve as ...
(Date:8/26/2020)... ST. CHARLES, Mo. (PRWEB) , ... ... ... Bioanalytical Services, a member of Eurofins BioPharma Services, Laboratory Testing division, expands ... to the existing suite of Flow Cytometry platforms available. With industry-leading biomarker ...
(Date:8/26/2020)... (PRWEB) , ... August 26, 2020 , ... Hero ... a target goal of 115 million 3 ply surgical disposable face masks and N95 ... is in direct response to the challenge that most Americans are facing in trying ...
Breaking Medicine Technology:
Cached News: